R-2187

N/A

Report date: 2025/01/26 17:36:48

Base Information

Drug NameR-2187
Drug Alias Namemicrobiome based probiotic (Rise Therapeutics)reprogramed Lactobacillus acidophilus (Rise Therapeutics)R-2187
ClassificationBiologics
Mechanisms of ActionMicrobiome modulatorsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRise Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesRise Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel DiseasesColitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A